Handelsbanken Fonder’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Handelsbanken Fonder’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,644	Closed	-$861K	–	1644
2022 Q3	$861K	Hold	12,644	–	–	0.01%	708
2022 Q2	$404K	Hold	12,644	–	–	﹤0.01%	1150
2022 Q1	$438K	Hold	12,644	–	–	﹤0.01%	1301
2021 Q4	$370K	Hold	12,644	–	–	﹤0.01%	1538
2021 Q3	$322K	Hold	12,644	–	–	﹤0.01%	1570
2021 Q2	$443K	Hold	12,644	–	–	﹤0.01%	1465
2021 Q1	$515K	Hold	12,644	–	–	﹤0.01%	1186
2020 Q4	$548K	Hold	12,644	–	–	﹤0.01%	1111
2020 Q3	$697K	Hold	12,644	–	–	0.01%	836
2020 Q2	$798K	Buy	+12,644	New	+$867K	0.01%	776

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Handelsbanken Fonder's GBT Position: Q4 2022 in Review

Handelsbanken Fonder sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 12,644 shares — an estimated $861K sold.

Handelsbanken Fonder first reported a position in GBT in Q2 2020 and held it in 10 quarters. The position peaked at $861K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Handelsbanken Fonder reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Handelsbanken Fonder sold 12,644 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $861K.
Handelsbanken Fonder first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 10 quarters.
Handelsbanken Fonder's Global Blood Therapeutics, Inc. position peaked at $861K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.